October 2012 Innovation Grants results

We are pleased to announce the results of the most recent Innovation Grants competition to support unique and creative research ideas that will impact cancer. Below is a listing of newly awarded Canadian Cancer Society (CCS) Innovation Grants.

Out of a total of 204 grant applications, 37 Canadian Cancer Society Innovation Grants have been approved – an 18% success rate. All grants have been awarded to a maximum budget of $200,000 with a maximum 3 year term. The 37 grants total over $7.2 million in funding over the terms of these grants. As a result of the very high quality of applications, additional funds were allocated to support greater than the 15-20 grants originally budgeted for this competition.

We are also very pleased that all grants are being funded to their full panel recommended amounts and that no administrative decrements are being applied.

Funds committed to this competition have been made possible by the significant efforts of Canadian Cancer Society volunteers and donors across the country.

Summaries of awarded grants

Please note:

Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.

The start date for these grants is February 1, 2013.

Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.

Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant.

Applicant
Institution
Title
Award
Bilodeau, Steve
CHUQ Centre Hospitalier Universitaire de Quebec
Controling the cancer-specific gene expression program
2013/2014 :  $100,000
2014/2015 :  $100,000
Broady, Raewyn
University of British Columbia
Generation of antigen specific T regulatory cells to treat GVHD post allogeneic stem cell transplant
2013/2014 :  $87,978
2014/2015 :  $87,978
Collins, Colin
Vancouver Hospital & Health Sciences Centre
Identification of critical players driving development of treatment resistant neuroendocrine prostate cancer
2013/2014 :  $99,935
2014/2015 :  $99,935
Danska, Jayne
Hospital for Sick Children
Development of novel anti-SIRPa antibody therapy for leukemia and leukemia stem cells
2013/2014 :  $100,000
2014/2015 :  $100,000
Fang, Qiyin
McMaster University
Colon mapping and colonoscopic localization using near infrared imaging of vascular patterns
2013/2014 :  $59,500
2014/2015 :  $79,000
2015/2016 :  $55,500
Flamand, Louis
CHUQ Centre Hospitalier Universitaire de Quebec
Autocrine and paracrine roles for lysophosphatidic acid in tumour cell growth
2013/2014 :  $100,000
2014/2015 :  $100,000
Friedenreich, Christine
Alberta Health Services (Alberta Cancer Board)
Alberta physical activity (ALPHA) and breast cancer prevention trial: An ancillary study examining anti-inflammatory markers and oxidative stress
2013/2014 :  $100,000
2014/2015 :  $66,351
Geyer, Clarence
University of Saskatchewan
Design of novel synthetic bi-specific EphB6/EphB4-activating antibodies for suppressing breast cancer metastasis
2013/2014 :  $99,983
2014/2015 :  $99,983
Ghert, Michelle
McMaster University
Prophylactic antibiotic regimens in tumour surgery (PARITY): A randomized multi-center clinical trial
2013/2014 :  $99,992
2014/2015 :  $99,055
Gibson, Spencer
Manitoba Institute of Cell Biology
Lysosome-mediated cell death in chronic lymphocytic leukemia
2013/2014 :  $54,360
2014/2015 :  $72,820
2015/2016 :  $72,820
Graham, Simon
Sunnybrook Research Institute
Improved functional magnetic resonance imaging for pre-surgical planning of brain tumours
2013/2014 :  $100,000
2014/2015 :  $85,055
Hung, Rayjean
Mount Sinai Hospital
Cell-free DNA whole-genome methylation profiles of pancreatic cancer for early detection and clinical outcome
2013/2014 :  $99,925
2014/2015 :  $99,975
Juncker, David
McGill University
Blood-based protein test for early detection of breast cancer using antibody colocalization microarrays
2013/2014 :  $100,000
2014/2015 :  $90,000
Koromilas, Antonis
Lady Davis Institute
Therapeutic implications of Stat1-p27 pathway disruption in Ras tumours
2013/2014 :  $99,500
2014/2015 :  $99,500
Lange, Dirk
University of British Columbia
The use of caulobacter crescentus as a novel microbial approach to treat bladder cancer
2013/2014 :  $92,790
2014/2015 :  $92,790
Litchfield, David
University of Western Ontario
Design of kinosensors as novel tools for cancer diagnosis
2013/2014 :  $100,000
2014/2015 :  $100,000
Moffat, Jason
University of Toronto
Generation and functional characterization of synthetic antibodies specific to colon cancer stem cell antigens identified from functional genomics
2013/2014 :  $100,000
2014/2015 :  $100,000
Nelson, Brad
BC Cancer Agency (Victoria)
The mutated lymphoma genome: A target for therapeutic vaccination
2013/2014 :  $100,000
2014/2015 :  $100,000
O'Brien, Catherine
Ontario Cancer Institute/PMH - UHN
The role of intracellular bacteria in colorectal cancer pathogenesis
2013/2014 :  $100,000
2014/2015 :  $100,000
Ohh, Michael
University of Toronto
Role of VHL in DNA damage response
2013/2014 :  $100,000
2014/2015 :  $100,000
Phenix, Christopher
Thunder Bay Regional Research Institute
Activatable probes for imaging protease activity in the tumour and tumour environment: A potential method for the early detection of aggressive cancer
2013/2014 :  $100,000
2014/2015 :  $90,494
Porter, Lisa
University of Windsor
Role of Spy1 in neurogenesis: Implications in the development of high grade glioma
2013/2014 :  $91,522
2014/2015 :  $94,397
Rafei, Moutih
University of Montreal
Interleukin-21-based therapy for T-cell reconstitution following bone marrow transplantation
2013/2014 :  $79,047
2014/2015 :  $67,606
2015/2016 :  $52,606
Ralhan, Ranju
Mount Sinai Hospital
Development of novel therapeutic agents for oral cancer
2013/2014 :  $100,000
2014/2015 :  $100,000
Reilly, Raymond
University of Toronto
Positron emission tomography (PET) theranostics for pancreatic cancer
2013/2014 :  $100,000
2014/2015 :  $100,000
Rhodes, Ryan
University of Victoria
Exercise games and physical activity: Does multi-player online play improve adherence?
2013/2014 :  $100,000
2014/2015 :  $97,324
Roberge, Michel
University of British Columbia
Chemical inhibition of SQSTM1/p62 in pancreatic cancer
2013/2014 :  $94,232
2014/2015 :  $94,232
Siu, K.W. Michael
York University
Prognostic pathway-centric signatures in glioblastoma multiforme
2013/2014 :  $94,490
2014/2015 :  $90,490
Spaner, David
Sunnybrook Research Institute
Multi-nuclear receptor blockade as a strategy to improve leukemia immunotherapy
2013/2014 :  $100,000
2014/2015 :  $100,000
Stambolic, Vuk
Ontario Cancer Institute/PMH - UHN
Insulin receptor expression and signalling pathway activation in human cancer
2013/2014 :  $100,000
2014/2015 :  $100,000
Stanisz, Greg
Sunnybrook Research Institute
Chemical exchange saturation transfer MRI as a marker of cancer therapy
2013/2014 :  $66,051
2014/2015 :  $66,052
2015/2016 :  $66,053
Tremblay, Michel
McGill University
Modulating T cell protein tyrosine phosphatase expression for T cell-based cancer immunotherapy
2013/2014 :  $66,666
2014/2015 :  $66,667
2015/2016 :  $66,667
Tsao, Ming-Sound
Ontario Cancer Institute/PMH - UHN
Epigenetic mechanism of resistance to epidermal growth factor receptor (EGFR) inhibitor therapy in lung adenocarcinoma
2013/2014 :  $96,500
2014/2015 :  $96,500
Wallace, Valerie
Ottawa Hospital Research Institute
Investigating the role of cross talk between medulloblastoma-forming neural progenitors and the microenvironment in tumour initiation
2013/2014 :  $66,400
2014/2015 :  $66,400
2015/2016 :  $67,200
White, John
McGill University
Novel fully-integrated hybrid drugs as anti-cancer therapeutics
2013/2014 :  $100,000
2014/2015 :  $100,000
Wulff, Jeremy
University of Victoria
Small-molecule inhibitors of the PD1-PDL1 interaction for treating metastatic cancer
2013/2014 :  $100,000
2014/2015 :  $100,000
Yaffe, Martin
Sunnybrook Research Institute
A multiplex imaging technique for prognostic biomarkers in DCIS
2013/2014 :  $100,000
2014/2015 :  $59,220
2015/2016 :  $34,670

Last modified on: August 12, 2014